News

Filter

1 to 9 of 19 results

ERS 2014: Mundipharma reports positive Ph III results for flutiform in pediatric asthma

ERS 2014: Mundipharma reports positive Ph III results for flutiform in pediatric asthma

08-09-2014

UK inhalation drug delivery specialist Skyepharma today announced that data from a randomized, multicenter,…

FlutiformGermanyMundipharmaPharmaceuticalPulmonologyResearchRespiratory and PulmonaryRespiratory therapySkyepharmaUK

Skyepharma launches Flutiform in France for asthma

10-02-2014

UK drug delivery specialist Skyepharma has received regulatory approval and agreement on pricing reimbursement…

FlutiformFranceMarkets & MarketingMundipharmaPharmaceuticalRespiratory and PulmonarySkyepharma

Kyorin expects $10 million sales after Flutiform launch in Japan for asthma

Kyorin expects $10 million sales after Flutiform launch in Japan for asthma

19-11-2013

UK drug delivery specialist Skyepharma (LSE: SKP) has announced that Flutiform has been launched in Japan…

Asia-PacificFlutiformKyorin PharmaceuticalsLicensingPharmaceuticalRegulationRespiratory and PulmonarySkyepharma

Flutiform trial for COPD initiated in Europe

Flutiform trial for COPD initiated in Europe

19-09-2013

UK drug delivery specialist Skyepharma (LSE: SKP) and privately-held Swiss drugmaker Mundipharma, which…

FlutiformMundipharmaPharmaceuticalResearchRespiratory and PulmonarySkyepharma

Flutiform recommended for approval in Japan

01-08-2013

UK drug delivery specialist Skyepharma (LSE SKP) revealed yesterday (July 31) that the Pharmaceutical…

Asia-PacificFlutiformKyorin PharmaceuticalsPharmaceuticalRegulationRespiratory and PulmonarySkyepharma

SkyePharma partner Kyorin files for Flutiform approval in Japan

26-09-2012

UK drug delivery specialist SkyePharma (LSE: SKP) says that its Japanese development and marketing partner…

Asia-PacificFlutiformKyorin PharmaceuticalsNapp PharmaceuticalsPharmaceuticalRegulationRespiratory and PulmonarySkyepharma

SkyePharma/Mundipharma's Flutiform launched in Germany

23-09-2012

UK-based drug delivery specialist SkyePharma (LSE: SKP) last Friday announced the launch of Flutiform,…

EuropeFlutiformMarkets & MarketingMundipharmaPharmaceuticalRespiratory and PulmonarySkyepharma

1 to 9 of 19 results

COMPANY SPOTLIGHT

Menarini

Back to top